23andMe’s failure shows how risky it can be to invest in a SPAC
The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...
23andMe is potentially selling more than just genetic data. The personal survey info is also a privacy problem.
Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.
‘People should be worried’: 23andMe bankruptcy could expose customers’ genetic data
The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...
How to Delete Your 23andMe Data
Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.
DNA testing firm 23andMe files for bankruptcy as demand dries up
Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...
Hiltzik: 23andMe files for bankruptcy, putting its hoard of personal health information at risk
23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...
23andMe Wins Court Approval to Sell DNA Data While Privacy Concerns Rise
Detailed price information for 23Andme Holding Co. (ME-Q) from The Globe and Mail including charting and trades.
Morningstar3d
23andMe's failure shows how risky it can be to invest in a SPAC
Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...
MarketWatch4d
23andMe’s failure shows how risky it can be to invest in a SPAC
23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...